Assurant: Q1 Earnings Snapshot
- On May 5, 2026, The Chemours Company reported first-quarter 2026 net sales of $1.4 billion, reflecting a one percent increase compared to the prior-year quarter.
- Chemours President and CEO Denise Dignam stated the results demonstrate the firm's 'Pathway to Thrive strategy' while noting that the wider economic landscape remains uncertain.
- First-Quarter net loss attributable to Chemours was $29 million, or $0.19 per diluted share, driven by increased financing costs and higher Selling, General and Administrative costs.
- Completing the sale of nine Kuan Yin site parcels in April 2026 provided approximately $287 million in net proceeds, allowing the company to reduce outstanding debt.
- The Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share, reflecting confidence in the company's flexible commercial and operational strategies for the remainder of 2026.
193 Articles
193 Articles
Network 1 Reports First Quarter 2026 Financial Results
NEW CANAAN, CT / ACCESS Newswire / May 8, 2026 / Network‑1 Technologies, Inc. (NYSE American:NTIP) ("Network‑1"), a company specializing in the acquisition, development, licensing and monetization of its intellectual property assets, today announced financial results for the quarter ended…
INmune Bio Inc. (INMB) Q1 2026 Earnings Call Prepared Remarks Transcript
Operator Greetings, and welcome to the INmune Bio’s 2026 First Quarter Earnings Call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce Mr. Daniel Carlson, Head of Investor Relations of INmune Bio. Daniel CarlsonHead of Investor Relations Thank you, operator, and good afternoon, everyone. We thank you for joining us for the call for IN…
Sohu.com to Report First Quarter 2026 Financial Results on May 18, 2026
BEIJING, May 8, 2026 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), a leading Chinese online media platform and game business group, will report its first quarter 2026 unaudited financial results on Monday, May 18, 2026, before U.S. market hours.
M-tron Industries, Inc. Reports First Quarter 2026 Results
Revenues increased 15.3%, or $2.0 million, to $14.7 million for the three months ended March 31, 2026 from $12.7 million for the three months ended March 31, 2025Gross margin improved to 44.9% for the three months ended March 31, 2026…
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial…
Coverage Details
Bias Distribution
- 54% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


























